APOC3 and diabetes mellitus: The finding that APOC3 immunoreactivity colocalizes (indicated by orange/yellow areas) with APOB supports the hypothesis the APOC3-containing lipoprotein particles accumulating in lesions in the setting of diabetes may be remnant lipoprotein particles.